Impact of Suvorexant on Sympathetic Nerve Activity and Baroreflex Function in Chronic Insomnia

NCT03768713 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Chronic Insomnia

Interventions

DRUG: Suvorexant
DRUG: Placebo

Sponsor

Montana State University

Collaborators

[object Object]